Gentian Diagnostics ASA reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was NOK 30.1 million compared to NOK 24.57 million a year ago. Revenue was NOK 32.88 million compared to NOK 31.5 million a year ago. Net loss was NOK 2.99 million compared to NOK 3.51 million a year ago. Basic and diluted loss per share was NOK 0.19 compared to NOK 0.23 a year ago.
For the six months, sales was NOK 50.65 million compared to NOK 44.21 million a year ago. Revenue was NOK 55.97 million compared to NOK 55.71 million a year ago. Net loss was NOK 9.62 million compared to NOK 8.44 million a year ago.